Literature DB >> 11080152

Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells.

S Sengupta1, J L Vonesch, C Waltzinger, H Zheng, B Wasylyk.   

Abstract

The tumour suppressor p53 and the glucocorticoid receptor (GR) respond to different types of stress. We found that dexamethasone-activated endogenous and exogenous GR inhibit p53-dependent functions, including transactivation, up- (Bax and p21(WAF1/CIP1)) and down- (Bcl2) regulation of endogenous genes, cell cycle arrest and apoptosis. GR forms a complex with p53 in vivo, resulting in cytoplasmic sequestration of both p53 and GR. In neuroblastoma (NB) cells, cytoplasmic retention and inactivation of wild-type p53 involves GR. p53 and GR form a complex that is dissociated by GR antagonists, resulting in accumulation of p53 in the nucleus, activation of p53-responsive genes, growth arrest and apoptosis. These results suggest that molecules that efficiently disrupt GR-p53 interactions would have a therapeutic potential for the treatment of neuroblastoma and perhaps other diseases in which p53 is sequestered by GR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11080152      PMCID: PMC305812          DOI: 10.1093/emboj/19.22.6051

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  91 in total

1.  RB regulates the stability and the apoptotic function of p53 via MDM2.

Authors:  J K Hsieh; F S Chan; D J O'Connor; S Mittnacht; S Zhong; X Lu
Journal:  Mol Cell       Date:  1999-02       Impact factor: 17.970

2.  A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking.

Authors:  J M Stommel; N D Marchenko; G S Jimenez; U M Moll; T J Hope; G M Wahl
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

3.  c-Abl neutralizes the inhibitory effect of Mdm2 on p53.

Authors:  R V Sionov; E Moallem; M Berger; A Kazaz; O Gerlitz; Y Ben-Neriah; M Oren; Y Haupt
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

4.  Glucocorticoids inhibit serum depletion-induced apoptosis in T lymphocytes expressing Bcl-2.

Authors:  S T Huang; J A Cidlowski
Journal:  FASEB J       Date:  1999-03       Impact factor: 5.191

5.  p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor.

Authors:  V Budhram-Mahadeo; P J Morris; M D Smith; C A Midgley; L M Boxer; D S Latchman
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

Review 6.  Cellular physiology and molecular events in hypoxia-induced apoptosis.

Authors:  C Riva; C Chauvin; C Pison; X Leverve
Journal:  Anticancer Res       Date:  1998 Nov-Dec       Impact factor: 2.480

7.  The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor.

Authors:  A Elkeles; T Juven-Gershon; D Israeli; S Wilder; A Zalcenstein; M Oren
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 8.  Mutagenesis of the glucocorticoid receptor in mice.

Authors:  C Kellendonk; F Tronche; H M Reichardt; G Schütz
Journal:  J Steroid Biochem Mol Biol       Date:  1999 Apr-Jun       Impact factor: 4.292

9.  p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53.

Authors:  C Wasylyk; R Salvi; M Argentini; C Dureuil; I Delumeau; J Abecassis; L Debussche; B Wasylyk
Journal:  Oncogene       Date:  1999-03-18       Impact factor: 9.867

10.  Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol.

Authors:  S Saji; S Nakashima; S Hayashi; M Toi; S Saji; Y Nozawa
Journal:  Jpn J Cancer Res       Date:  1999-02
View more
  30 in total

1.  Glucocorticoid receptor activation inhibits p53-induced apoptosis of MCF10Amyc cells via induction of protein kinase Cε.

Authors:  Moammir H Aziz; Hong Shen; Carl G Maki
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

Review 2.  The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases.

Authors:  Ioanna Petta; Lien Dejager; Marlies Ballegeer; Sam Lievens; Jan Tavernier; Karolien De Bosscher; Claude Libert
Journal:  Microbiol Mol Biol Rev       Date:  2016-05-11       Impact factor: 11.056

3.  Supervillin associates with androgen receptor and modulates its transcriptional activity.

Authors:  Huei-Ju Ting; Shuyuan Yeh; Kazuo Nishimura; Chawnshang Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

Review 4.  Nuclear receptors in inflammation control: repression by GR and beyond.

Authors:  Yurii Chinenov; Rebecca Gupte; Inez Rogatsky
Journal:  Mol Cell Endocrinol       Date:  2013-04-26       Impact factor: 4.102

5.  Acute kidney injury induces dramatic p21 upregulation via a novel, glucocorticoid-activated, pathway.

Authors:  Richard A Zager; Ali C M Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2019-01-30

6.  Negative cross talk between NFAT1 and Stat5 signaling in breast cancer.

Authors:  Jiamao Zheng; Feng Fang; Xianke Zeng; Terry R Medler; Alyson A Fiorillo; Charles V Clevenger
Journal:  Mol Endocrinol       Date:  2011-09-29

7.  Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2.

Authors:  S Sengupta; B Wasylyk
Journal:  Genes Dev       Date:  2001-09-15       Impact factor: 11.361

8.  Potential effects of CRM1 inhibition in mantle cell lymphoma.

Authors:  Ke-Jie Zhang; Michael Wang
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

9.  Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression.

Authors:  H Karimi Kinyamu; Trevor K Archer
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

10.  Quantitative proteomics analysis of the effects of ionizing radiation in wild type and p53 K317R knock-in mouse thymocytes.

Authors:  Lisa M Miller Jenkins; Sharlyn J Mazur; Matteo Rossi; Olga Gaidarenko; Yang Xu; Ettore Appella
Journal:  Mol Cell Proteomics       Date:  2008-01-04       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.